Impact of metformin therapy on serum visfatin levels in polycystic ovary syndrome: a systematic review and randomized permuted meta-analysis
Authors:
- Hemanth Raj ThangappazhamHTHemanth Raj Thangappazham
- Nabnita PatnaikNPNabnita Patnaik
- Pragathi DugginaPDPragathi Duggina
- Kuladeep L KumarKKKuladeep L Kumar
- Saurabh VarshneySVSaurabh Varshney
- Ashoo GroverAGAshoo Grover
- Pratima GuptaPGPratima Gupta
- Kumar Guru MishraKMKumar Guru Mishra
- Seshadri Reddy VarikasuvuSVSeshadri Reddy Varikasuvu
Open Access
- 20 February 2025
- journal article
- review article
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 71 (2) , 74-79
Abstract
Visfatin, an, is associated with reproductive and metabolic disorders like polycystic ovary syndrome (PCOS). Although visfatin levels are known to be elevated in PCOS, the effect of metformin treatment on these levels remains unclear. This meta-analysis aimed to assess changes in circulating visfatin levels before and after metformin intervention in PCOS patients. Relevant studies were identified through comprehensive searches, and a random-effects meta-analysis was conducted to calculate standardized mean differences (SMDs) with 95% confidence intervals (CIs). Sensitivity analysis and randomized permuted meta-analyses (with 1,000, 10,000, and 100,000 iterations) were performed to validate the findings. The analysis included four studies and showed a significant reduction in visfatin levels following metformin treatment (SMD: -0.45, 95% CI: -0.76 to -0.14, p = 0.0043). These results highlight metformins impact on visfatin levels in PCOS, though larger trials are needed to further explore visfatins role as a therapeutic target in PCOS.Keywords
This publication has 23 references indexed in Scilit:
- Adipose-derived extracellular vesicles – a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndromeEndocrine, 2024
- Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary SyndromeGenetic Testing and Molecular Biomarkers, 2020
- Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational studyScientific Reports, 2019
- Effects of Metformin on Endocrine and Metabolic Parameters in Patients with Polycystic Ovary SyndromeHormone and Metabolic Research, 2016
- Visfatin: A Potential Therapeutic Target for Rheumatoid ArthritisJournal of International Medical Research, 2009
- Effect of metformin on serum visfatin levels in patients with polycystic ovary syndromeFertility and Sterility, 2008
- The effect of metformin on serum visfatin in relation to polycystic ovarian syndrome, obesity and insulin resistanceFertility and Sterility, 2007
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary SyndromeJournal of Diabetes Science and Technology, 2007
- Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and PitfallsObstetrical & Gynecological Survey, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004